What is the main business of Superhumin?

The main business activity of Superhumin focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 16, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Traktorowa 196, 91-218 Łódź.

Who is on the management board?

The management board consists of: Piotr Bartłomiej Mazurkiewicz (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of USD 61,388, representing an increase of 122400.0% compared to 2023.

Is the company profitable?

Yes, the company recorded a net profit of USD 28,186 in 2024.

Superhuminsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-05-16

Share capital

5,000.00 PLN

Registered address

ul. Traktorowa 196, 91-218 Łódź, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 315 days for 2023).

2025not filed
202431/05/2025
202326/05/2025
202213/12/2023
202119/07/2022
202019/07/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 61.39kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD 28.19kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 31.53kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 40.08kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Piotr Bartłomiej Mazurkiewicz – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Barbara Mazurkiewiczage 75	50	$675.31	50%
Piotr Bartłomiej Mazurkiewiczage 49	50	$675.31	50%

Barbara Mazurkiewicz and Piotr Bartłomiej Mazurkiewicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2018-06-22.

Nest Bank
82 2530 0008 2059 1036 9516 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o.	$255,522.81	vetcomplex.pl
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Xenstatssp. z o.o.	$66,774.27	xenstats.com
Pominnosp. z o.o.	$65,991.17	pominno.pl
Luna Laboratorysp. z o.o.	$61,894.23	lunalab.pl
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.	$54,163.54	geneza.eu
Receptonsp. z o.o.	$50,611.05	receptonbiotech.com
Biostat Research and Developmentsp. z o.o.	$50,225.77	biostat.com.pl
GenomtecS.A.	$47,965.85	genomtec.com
Zawamedsp. z o.o.	$43,909.06	zawamed.pl

FAQ

Last updated: 2026-09-18